Skip to main content

Reduced EPO receptor expression may contribute to limited pleiotropic effects of EPO during critical illness


We showed neuroprotective and renoprotective effects of recombinant human erythropoietin (rhEPO) after kidney and spinal cord ischemia/reperfusion (I/R) injury [1, 2], but clinical studies using rhEPO to prevent acute kidney injury yielded equivocal results [3, 4]. Increased cytokine release and/or oxidative stress can cause EPO resistance due to receptor modification and/or downregulation [5]. Since we recently failed to confirm rhEPO-related kidney protection in atherosclerotic swine [6], we compared kidney EPO receptor expression in swine strains with and without pre-existing vascular disease and kidney dysfunction.


EPO receptor expression was quantified with immunohistochemistry (densitometric image analysis) of formalin-fixed paraffin sections from pre-injury kidney biopsies taken in young and healthy pigs (German Landrace, up to now n = 4) as well as swine (FBM strain, up to now n = 6) with familial hypercholesteremia (11.1 (7.4; 12.3) vs. 1.4 (1.3; 1.5) mmol/l, P < 0.001, n = 20 and 15, respectively, P < 0.001) and consecutive, diet-induced atherosclerosis [7].


Atherosclerotic swine presented with reduced glomerular filtration rate (creatinine clearance 76 (60; 83) vs. 103 (79; 120) ml/minute, n = 19 each, P = 0.004) and chronic histological kidney injury (dilatation of Bowman's space, swelling of Bowman's capsule, tubular dilatation and necrosis). EPO receptor expression was reduced by nearly two orders of magnitude in this strain (94.6 (8.3; 112.5)×107 vs. 1.7 (0.0; 4.7) ×107 densitometric units, P = 0.010).


Even pretreatment with rhEPO did not influence I/R-induced acute kidney in swine with pre-existing impairment of kidney function and histological damage. The lacking beneficial effect of rhEPO was most likely due to the reduced expression of the EPO receptor, which may also explain contradictory results in clinical trials due to the frequent underlying kidney disease in the patients recruited.


  1. 1.

    Simon F, et al.: Crit Care Med. 2008, 36: 2143-2150. 10.1097/CCM.0b013e31817d7912

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Simon F, et al.: Intensive Care Med. 2011, 37: 1525-1533. 10.1007/s00134-011-2303-4

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Song YS, et al.: Am J Nephrol. 2009, 30: 253-260. 10.1159/000223229

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Endre ZH, et al.: Kidney Int. 2010, 77: 1020-1030. 10.1038/ki.2010.25

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    van der Putten K, et al.: Nat Clin Pract Nephrol. 2008, 4: 47-57. 10.1038/ncpneph0655

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Simon F, et al.: Shock. 2011,36(Suppl 1):S24.

    Google Scholar 

  7. 7.

    Thim T: Dan Med Bull. 2010, 57: B4161.

    PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to O McCook.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

McCook, O., Matějková, S., Matallo, J. et al. Reduced EPO receptor expression may contribute to limited pleiotropic effects of EPO during critical illness. Crit Care 16, P440 (2012).

Download citation

  • Published:

  • DOI:


  • Acute Kidney Injury
  • Familial Hypercholesteremia
  • Recombinant Human Erythropoietin
  • Tubular Dilatation
  • Densitometric Unit